Halomine, Inso Biosciences Land Grants to Combat Disease Outbreak
Two members of Southern Tier Startup Alliance (STSA) incubators, Halomine and Inso Biosciences, were recently awarded nearly $3 million from the New York State Biodefense Commercialization Fund, via Empire State Development, to help impede future outbreaks of infectious disease and to continue growing the state’s life science industries.
The pair of startups were among 18 companies and educational institutions that received a combined $15.3 million in grants. Halomine, an antimicrobial coating technology company that graduated from Cornell’s Praxis Center for Venture Development incubator in June, received $2 million. Inso Biosciences, which currently incubates at Cornell’s Center for Life Science Ventures, received $955,000 to continue developing its genomic sample preparation platforms.